Propel Bio Management, LLC Portfolio Holdings

Propel Bio Management, LLC

  • $172 Billion
  • Q1 2024

Propel Bio Management, LLC has filed its 13F form on May 13, 2024 for Q1 2024 where it was disclosed a total value porftolio of $172 Billion distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Applied Therapeutics Inc. with a value of $41.6B, Simplify Exchange Traded Fds E with a value of $28B, T Scan Therapeutics, Inc. with a value of $16.6B, Madrigal Pharmaceuticals, Inc. with a value of $11.5B, and Achieve Life Sciences Inc with a value of $11.1B.

Examining the 13F form we can see an increase of $51.2B in the current position value, from $121B to 172B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $172 Billion
Healthcare: $124 Billion
ETFs: $2.56 Billion
Technology: $2.5 Billion
Financial Services: $1.47 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$206M
$41.6 Billion 24.19% of portfolio
6,111,906
Q1 2024 Added 13.71%
-
$28 Billion 16.29% of portfolio
-
Q1 2024 Added 1,141.53%
$162M
$16.6 Billion 9.65% of portfolio
2,087,139
Q4 2023 New
$4.04B
$11.5 Billion 6.69% of portfolio
43,032
Q1 2024 Added 43.29%
Achieve Life Sciences Inc
-
$11.1 Billion 6.49% of portfolio
-
Q1 2024 New
$369M
$9.24 Billion 5.38% of portfolio
869,927
Q1 2024 Added 96.35%
$874M
$8.28 Billion 4.82% of portfolio
327,752
Q1 2024 Added 227.58%
$409M
$7.08 Billion 4.12% of portfolio
750,000
Q4 2023 New
$1.4B
$4.56 Billion 2.65% of portfolio
178,500
Q4 2023 New
$975M
$4.47 Billion 2.6% of portfolio
270,664
Q4 2023 New
$1.06B
$4.34 Billion 2.52% of portfolio
594,174
Q4 2023 New
$99.1M
$4.09 Billion 2.38% of portfolio
1,492,792
Q4 2023 New
$1.38B
$2.77 Billion 1.61% of portfolio
130,000
Q4 2023 New
$135M
$2.5 Billion 1.46% of portfolio
290,781
Q4 2023 New
$1.76B
$2.27 Billion 1.32% of portfolio
56,359
Q4 2023 New
$0
$2.07 Billion 1.2% of portfolio
22,400
Q4 2023 New
$883M
$1.76 Billion 1.02% of portfolio
70,000
Q4 2023 New
Marinus Pharmaceuticals Inc
-
$1.63 Billion 0.95% of portfolio
-
Q4 2023 New
$0
$1.47 Billion 0.86% of portfolio
147,033
Q4 2023 New
$220M
$1.1 Billion 0.64% of portfolio
195,000
Q4 2023 New
$150M
$897 Million 0.52% of portfolio
260,000
Q1 2024 New
Eiger Biopharmaceuticals Inc
-
$732 Million 0.43% of portfolio
-
Q1 2024 New
$69.3M
$744 Million 0.43% of portfolio
535,000
Q4 2023 New
$0
$485 Million 0.28% of portfolio
4,456
Q4 2023 New
$58.1M
$351 Million 0.2% of portfolio
850,000
Q4 2023 New
Fidelity Inv Mmtrsy 1 680
-
$212 Million 0.12% of portfolio
-
Q1 2024 Reduced 95.57%
Chinook Therapeutics Inc Cvr
-
$30.9 Million 0.02% of portfolio
-
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $172 Billion
  • Prior Value $121 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 13, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 4 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email